Live Breaking News & Updates on Prnewswire inhibrx inc

Stay updated with breaking news from Prnewswire inhibrx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Ukraine , Brendan-eckelman , Prnewswire-inhibrx-inc , Exchange-commission , Inhibrx-inc , Securities-exchange , Company-annual-report-on-form , Nasdaq , Inhibrx-biosciences-inc , Company-on , Party-transactions , Company-definitive-proxy-statement

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Ukraine , Brendan-eckelman , Company-annual-report-on-form , Securities-exchange , Nasdaq , Exchange-commission , Prnewswire-inhibrx-inc , Inhibrx-inc , Company-definitive-proxy-statement , Party-transactions , Company-on , Inhibrx-biosciences-inc

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ukraine , Brendan-eckelman , Prnewswire-inhibrx-inc , Company-on , Company-definitive-proxy-statement , Party-transactions , Company-annual-report-on-form , Exchange-commission , Securities-exchange , Inhibrx-inc , Inhibrx-biosciences-inc , Nasdaq

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with three clinical programs in development and a strong...

Ukraine , Jon-faiz-kayyem , Kimberly-manhard , Douglas-forsyth , Securities-exchange , Aventis-inc , Inhibrx-inc , Party-transactions , Company-on , Inhibrx-biosciences-inc , Nasdaq , Prnewswire-inhibrx-inc

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares in New Inhibrx, a new publicly traded company that retains all non-101...

Ukraine , Pennsylvania , United-states , Kayyem-jon-faiz , Manhard-kimberly , Forsyth-douglas , Gotshal-manges , Inhibrx-biosciences-inc , Securities-exchange , Prnewswire-inhibrx-inc , Centerview-partners , Nasdaq

Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma

Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Rashmi-chugh , Prnewswire-inhibrx-inc , Nasdaq , Exchange-commission , Inhibrx-inc , Connective-tissue-oncology-society , Annual-connective-tissue-oncology-society , Internal-medicine , Michigan-rogel-comprehensive-cancer , Fast-track , Annual-report

Inhibrx Announces Participation in Upcoming Scientific Conferences

Inhibrx Announces Participation in Upcoming Scientific Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California , United-states , San-diego-convention-center , Dublin , Ireland , San-diego , Irish , Rashmi-chugh , Prnewswire-inhibrx-inc , Inhibrx-inc , Nasdaq , Connective-tissue-oncology-society

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare...

United-states , Japan , Canada , American , Chiesi-farmaceutici , Mark-lappe , Inhibrx-inc , Exchange-commission , Prnewswire-inhibrx-inc , Nasdaq , European-medicines-agency , North-american

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Japan , American , Mark-lappe , Chiesi-farmaceutici , European-medicines-agency , Nasdaq , Exchange-commission , Inhibrx-inc , Prnewswire-inhibrx-inc , North-american

Inhibrx Announces $200 Million Private Placement Financing

Inhibrx Announces $200 Million Private Placement Financing
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United-states , Nasdaq , Exchange-commission , Prnewswire-inhibrx-inc , Inhibrx-inc , Viking-global-investors , Perceptive-advisors , Securities-act , Looking-statements , Annual-report , Private-securities-litigation-reform-act